Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study
Latest Information Update: 22 Feb 2022
At a glance
- Drugs Empagliflozin (Primary)
- Indications Hyponatraemia
- Focus Pharmacodynamics
- Acronyms SAND
- 23 May 2019 Status changed from recruiting to completed.
- 07 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Apr 2019.
- 06 Feb 2018 Planned End Date changed from 1 Aug 2018 to 1 Apr 2019.